CD40LG and infection: The use of CD40 ligand (CD40L) [90] to cultivate B cells combined with T cells stimulated with monoclonal antibodies to TCR2 (anti-αVβ1) [91] allowed Schermuly et al. [92] to develop an efficient in vitro infection model for MDV.